Gonadotropin-releasing hormone-agonist as a neoadjuvant therapy for Sertoli-Leydig cell tumors of the ovary

被引:12
作者
Chao, HT
Wang, PH
Lin, HD
机构
[1] Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Vet Gen Hosp, Sch Med, Dept Med, Taipei 112, Taiwan
关键词
androgen-secreting ovarian tumor; gonadotropin-releasing hormone agonist; neoadjuvant therapy;
D O I
10.1016/S0020-7292(99)00071-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
[No abstract available]
引用
收藏
页码:189 / 190
页数:2
相关论文
共 4 条
[1]   Clinical case seminar - Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor [J].
Barnes, RB ;
Ehrmann, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1746-1748
[2]   ANDROGEN SUPPRESSIVE EFFECT OF GNRH AGONIST IN OVARIAN HYPERTHECOSIS AND VIRILIZING TUMORS [J].
PASCALE, MM ;
PUGEAT, M ;
ROBERTS, M ;
ROUSSET, H ;
DECHAUD, H ;
DUTRIEUXBERGER, N ;
TOURNIAIRE, J .
CLINICAL ENDOCRINOLOGY, 1994, 41 (05) :571-576
[3]  
SCHENCKER Y, 1989, OBSTET GYNECOL, V74, P502
[4]   Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary [J].
Wang, PH ;
Chao, HT ;
Lee, WL .
FERTILITY AND STERILITY, 1998, 69 (02) :353-355